These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6639104)

  • 1. [Experimental animal information file: effect of bestatin in muscular dystrophy in mice].
    Kawamata J
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2425-6. PubMed ID: 6639104
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of murine muscular dystrophy with the protease inhibitor bestatin.
    Tsuji S; Matsushita H
    J Neurol Sci; 1986 Feb; 72(2-3):183-94. PubMed ID: 3711932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationships between enzyme inhibitors and function of mammalian cells.
    Aoyagi T; Umezawa H
    Acta Biol Med Ger; 1981; 40(10-11):1523-9. PubMed ID: 7044007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic trials on progressive muscular dystrophy.
    Satoyoshi E
    Intern Med; 1992 Jul; 31(7):841-6. PubMed ID: 1450492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a cysteine protease inhibitor EST on urinary 3-methylhistidine in dystrophic hamsters (BIO 14.6)].
    Terao T; Mashino K; Takatsu M; Hiraguchi M
    Rinsho Shinkeigaku; 1986 Nov; 26(11):1218-23. PubMed ID: 3549099
    [No Abstract]   [Full Text] [Related]  

  • 6. Beneficial effect of new thiol protease inhibitors, epoxide derivatives, on dystrophic mice.
    Komatsu K; Inazuki K; Hosoya J; Satoh S
    Exp Neurol; 1986 Jan; 91(1):23-9. PubMed ID: 3940877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cell-penetrating alpha-keto-amide calpain inhibitors as potential treatment for muscular dystrophy.
    Lescop C; Herzner H; Siendt H; Bolliger R; Henneböhle M; Weyermann P; Briguet A; Courdier-Fruh I; Erb M; Foster M; Meier T; Magyar JP; von Sprecher A
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5176-81. PubMed ID: 16185867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of muscle diseases, Part III: Compilation of therapeutic trials for hereditary muscular dystrophy.
    Cosmos E; Butler J
    Muscle Nerve; 1980; 3(5):427-35. PubMed ID: 7421876
    [No Abstract]   [Full Text] [Related]  

  • 9. The stabilizing effect of bestatin on the resting membrane potentials of X-linked muscular dystrophy mice.
    Kishi M; Kurihara T; Hidaka T; Kinoshita M
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):595-600. PubMed ID: 2074619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of life span of dystrophic hamster by cysteine proteinase inhibitor, loxistation (EST).
    Tamai M; Omura S; Kimura M; Hanada K; Sugita H
    J Pharmacobiodyn; 1987 Nov; 10(11):678-81. PubMed ID: 3482108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
    Bizario JC; Cerri DG; Rodrigues LC; Oliveira GL; Nomizo A; de Araujo DD; Fukuhara PS; Ribeiro JC; de Castro FA; Costa MC
    J Neuroimmunol; 2009 Jul; 212(1-2):93-101. PubMed ID: 19508953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of 5-hydroxytryptamine antagonists on inherited muscular dystrophy in the chicken and hamster [proceedings].
    Barnard EA; Barnard PJ
    J Physiol; 1978 May; 278():29P-30P. PubMed ID: 671302
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the pathogenesis of muscular dystrophy: superoxide dismutase activity in avian muscular dystrophy].
    Mizuno Y; Joshita Y; Kaneko J
    No To Shinkei; 1982 Jul; 34(7):667-72. PubMed ID: 7138694
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteinase inhibitors and muscle degeneration.
    Stracher A
    Muscle Nerve; 1982; 5(6):494. PubMed ID: 7133046
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of thiorphan, bestatin and captopril on the Lewis lung carcinoma metastases in mice.
    Kowalski J; Belowski D; Madej A; Herman ZS
    Pol J Pharmacol; 1995; 47(5):423-7. PubMed ID: 8868134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of drug regimen exceeds electrostimulation in treatment of avian muscular dystrophy.
    Hudecki MS; Povoski SP; Gregorio CC; Granchelli JA; Pollina CM
    J Appl Physiol (1985); 1995 Jun; 78(6):2014-9. PubMed ID: 7665393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A drug inhibits the mitochondrial protease inducing calmitine deficiency in skeletal muscle of patients with Duchenne's muscular dystrophy and dy/dy dystrophic mice.
    Lucas-Heron B
    Biochem Biophys Res Commun; 1997 Mar; 232(2):559-61. PubMed ID: 9125222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of bestatin and thiorphan in mice.
    Kowalski J; Belowski D; Madej A; Herman ZS
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):265-71. PubMed ID: 8744646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug evaluation in muscular dystrophy of the chicken.
    Entrikin RK; Patterson GT; Wilson BW
    Muscle Nerve; 1982 Apr; 5(4):321-7. PubMed ID: 7099198
    [No Abstract]   [Full Text] [Related]  

  • 20. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.
    Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y
    Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.